🚨1st SHORE pub‼️ > 2k🫀transplants, dual non-invasive rejection surveillance with GEP & dd-cfDNA:
1. ⬆️yield for ACR over either test alone
2. ⬇️number of biopsies
3. Great survival and🫀LVEF
Kiran Khush JHLT The ISHLT American Society of Transplantation (AST) HFSA Nir Uriel, MD MSc
jhltonline.org/article/S1053-…

Presented at the HFA meeting and simultaneous publication in @JAMA. In this study of 4 large cohorts (ARIC, MESA, REGARDS, WHI) pooling >23,000 self-reported Black participants, the prevalence of the V142I variant was 3.2%. jamanetwork.com/journals/jama/…

The society's flagship journal, The Journal of Heart and Lung Transplantation (JHLT), has named Joseph Rogers, MD, as the new editor-in-chief of the Journal. 📚 Read more about Dr. Roger's appointment at 🔗 bit.ly/3Qsce4K

Congratulations, Joseph Rogers! 🎉

⏳early registration for #ISA2024 ending soon. Virtual & in person, state of the art #amyloidosis Amyloidosis_ARC Amyloidosis Support Mayo Amyloid BU Amyloidosis Center MUSC Amyloidosis Center Mayo Clinic CV Michelle Kittleson MD PhD Brett Sperry, MD Ahmad Masri Mazen Hanna cveducation.mayo.edu/store/internat…

Congrats to former ⁦Johns Hopkins Medicine⁩ ⁦Johns Hopkins Cardiology⁩ ⭐️’s ⁦Michelle Kittleson MD PhD⁩ & ⁦Khurram Nasir⁩ for being named Associate Editors at ⁦JACC Journals⁩ under head coach & GM ⁦Harlan Krumholz⁩ - the future of 🫀journalism is super bright.

This is really good.

Congrats ⁦Frederick L Ruberg⁩ and ⁦mathew.maurer⁩!

Cardiac Amyloidosis Due to Transthyretin Protein: A Review | Cardiology | JAMA | JAMA Network jamanetwork.com/journals/jama/…

In patients with arrhythmogenic cardiomyopathy, left ventricular involvement is associated more with heart failure, heart transplantation, and hot phases. bit.ly/49KFYRu

#JACC #HeartFailure #HeartTx #CardioX

What a fantastic approach to a standardized definition of ADHF.
J Am Coll Cardiol HF 2024;12:1–15

An implantable hemodynamic monitor significantly reduces both mortality and HF 🏨 in HFrEF

Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction | Journal of the American College of Cardiology jacc.org/doi/10.1016/j.…

From Chantal van Opbergen Mario Delmar Marina Cerrone + team: AAV-Mediated Delivery of PKP2a Arrests Progression of ARVC in Murine Hearts: Preclinical Evidence Supporting Gene Therapy in Humans

ahajournals.org/doi/abs/10.116…

AHA Science #AHAjournals #CardioTwitter #Genetics

📽️H.J. Tadros

📌Kidney Involvement in Transthyretin Cardiac Amyloidosis

✅Role of UACR and Need for Further Evidence Generation

Editorial: onlinelibrary.wiley.com/doi/10.1002/ej…

Original Article: onlinelibrary.wiley.com/doi/10.1002/ej…

With the expanding role for SGLT2i’s & GLP-1Ra’s in #HF , metabolism is always on our minds…🤔

Luckily, in this month’s issue of #JACCBTS , Vite, et al. test varying metabolic substrates for cardiomyocytes (CMs). Join us to find their favorite diet; no Ozempic necessary! 🧵1/11

Prognostic Utility of PET & SPECT MPI for Cardiovascular Events Post Kidney Transplant

• PET MPI findings predict post-transplant MACE. Abnormal PET linked to risk (HR 3.02), abnormal SPECT 🚫conclusive
•Normal PET may better discriminate lower-risk patients vs normal SPECT

Is apical sparing on echo sufficient for the diagnosis of cardiac amyloidosis? In this multicenter study, we identified 544 patients with CA and 200 controls (suspicion for CA but ruled out for CA), as well as 174 healthy subjects. Led by Jeremy Slivnick academic.oup.com/ehjcimaging/ad…

A huge congratulations to the investigators & my MUSC Health colleague #DanJudge for his leadership of this study! MUSC-CardiologyFellowshipPrograms Keyur B. Shah mathew.maurer Jan Griffin
Efficacy & Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy | NEJM nejm.org/doi/full/10.10…

We developed 5 VAD-specific measures to assess adjustment to living with a #VAD and HRQOL. Measure use may assist VAD clinicians to inform patients about VADs as a treatment option and guide post-VAD therapies.

🔗 jhltonline.org/article/S1053-…

Fun collaboration between MUSC Electrophysiology & Brigham EP reporting potential inflammatory link between #COVID and #sarcoid link arrhytmogenic substrate. Leah A. John, MD Usha Tedrow William H. Sauer, MD Sanjay Divakaran Brian Houston MD

How do you risk stratify candidates for LVADs? Former MUSC Health AHFTC fellow Jagpreet Grewal led this Multi-Center Evaluation of the HeartMate 3 Risk Score JHLT jhltonline.org/article/S1053-…

While HM3RS was less predictive in non-trial populations, outcomes were still excellent.

Thoughts on how we can continue to innovate LVAD care. We currently utilize only a fraction of the info that these amazing machines can provide. Palak Shah @LukeZiegler JHLT Abbott Cardiovascular

Next Generation Device Interrogation for the HeartMate 3 sciencedirect.com/science/articl…